Literature DB >> 15167724

Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline.

David M Kwiat1, Thomas A Bersani, Adam Bersani.   

Abstract

PURPOSE: To demonstrate that injection of botulinum toxin type A is less painful when mixed with preserved saline compared with the suggested preservative-free saline reconstitution.
METHODS: Two different injections were compared on 20 patients who had prior botulinum toxin type A treatments. Each side was injected with toxin reconstituted with either preserved or nonpreserved (0.9%) saline. The investigators and patients were blinded, and outcome was assessed with a verbal scale. Clinical outcome was subjectively and informally assessed by patient questioning and physician observation.
RESULTS: Injection of botulinum toxin type A was noted to be less painful with the use of the preserved compared with the nonpreserved preparation (P<0.0001). The preserved reconstitution appeared to have no effect on clinical outcome.
CONCLUSIONS: Injection of botulinum toxin reconstituted with preserved saline is less painful than nonpreserved saline preparations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167724     DOI: 10.1097/01.iop.0000129012.09632.49

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  8 in total

Review 1.  Comparison and overview of currently available neurotoxins.

Authors:  Thomas J Walker; Steven H Dayan
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

Review 2.  Noninvasive Facial Rejuvenation. Part 2: Physician-Directed-Neuromodulators and Fillers.

Authors:  Ryan M Dickey; Matthew R Louis; Joshua A Cox; Kriti Mohan; Edward I Lee; Marjory G Nigro
Journal:  Semin Plast Surg       Date:  2016-08       Impact factor: 2.314

3.  Noncosmetic periocular therapeutic applications of botulinum toxin.

Authors:  Pelin Kaynak-Hekimhan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

4.  Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: A placebo-controlled, blinded, randomized trial.

Authors:  Helka M Heikkilä; Tarja S Jokinen; Pernilla Syrjä; Jouni Junnila; Anna Hielm-Björkman; Outi Laitinen-Vapaavuori
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

Review 5.  Botulinum neurotoxin formulations: overcoming the confusion.

Authors:  Souphiyeh Samizadeh; Koenraad De Boulle
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-30

Review 6.  Bacteriostatic preserved saline for pain-free periocular injections: review.

Authors:  Samantha Vicki Hunt; Raman Malhotra
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 4.456

Review 7.  Botulinum Toxin in Aesthetic Medicine: Myths and Realities.

Authors:  Jeffrey S Dover; Gary Monheit; Mark Greener; Andy Pickett
Journal:  Dermatol Surg       Date:  2018-02       Impact factor: 3.398

8.  The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Authors:  Mark S Nestor; David Arnold; Daniel Fischer
Journal:  J Cosmet Dermatol       Date:  2020-09-16       Impact factor: 2.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.